Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inactivation of alpha-hemolysin limits the virulence of S. aureus [108–114].”
From Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity (2012) · cites this paper as [110]
In the citing paper
“The ability of staphylococci to acquire heme and hemoproteins in vivo is facilitated by lysis of host erythrocytes by pore-forming toxins such as alpha-hemolysin (encoded by hla) (Fig. 1).”
From Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity (2012) · cites this paper as [110]
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,370
Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia
Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., Benito, Y., Barbu, E. M., Vazquez, V., Höök, M., Etienne, J., et al. (2007) · Science · doi:10.1126/science.1137165 · Cited by 709
Voyich, J. M., Otto, M., Mathema, B., Braughton, K. R., Whitney, A. R., Welty, D., Long, R. D., Dorward, D. W., Gardner, D. J., Lina, G., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509506 · Cited by 565
Self-citationSurface Proteins and Exotoxins Are Required for the Pathogenesis of Staphylococcus aureus Pneumonia
Wardenburg, J. B., Patel, R. J., & Schneewind, O. (2007) · Infection and Immunity · doi:10.1128/iai.01313-06 · Cited by 348
Self-citationKaneko, J., Kimura, T., Narita, S., Tomita, T., & Kamio, Y. (1998) · Gene · doi:10.1016/s0378-1119(98)00278-9 · Cited by 231
Gouaux, E., Hobaugh, M., & Song, L. (1997) · Protein Science · doi:10.1002/pro.5560061216 · Cited by 119
Research works printed but not linked: 1
- Gladstone, G.P. & van Heyningen, W.E. Br. J. Exp. Pathol. 38, 123–137 (1957).
Cited by
Items 201–300 of 496
Population genetics and the evolution of virulence in Staphylococcus aureus
Chua, K., Howden, B. P., Jiang, J., Stinear, T. P., & Peleg, A. Y. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.04.026 · Cited by 59
Cheung, G. Y. C., & Otto, M. J. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.682573 · Cited by 52
Self-citationLooking toward basic science for potential drug discovery targets against community‐associated MRSA
Otto, M. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20160 · Cited by 54
Self-citationInduction of Virulence Gene Expression in Staphylococcus aureus by Pulmonary Surfactant
Ishii, K., Adachi, T., Yasukawa, J., Suzuki, Y., Hamamoto, H., & Sekimizu, K. (2014) · Infection and Immunity · doi:10.1128/iai.01635-13 · Cited by 51
Patel, M. (2009) · Drugs · doi:10.2165/00003495-200969060-00004 · Cited by 58
“[108-110] Defining CA- and HA-MRSA on clinical risk factors alone is becoming less useful as these strains intermingle within the healthcare setting.”
BackgroundInfluentialStaphylococcus aureus: an introduction
Myles, I. A., & Datta, S. K. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0301-9 · Cited by 62
Baranovich, T., Zaraket, H., Shabana, I., Афанасьевна, Н. В., Turcutyuicov, V. B., & Suzuki, H. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02891.x · Cited by 49
“[28] failed to observe a significant difference in virulence in a mouse pneumonia model that examined the ‘R variant’ PVL strains.”
Lo, W., & Wang, C. (2011) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2011.02.008 · Cited by 59
Olsen, R. J., Kobayashi, S. D., Ayeras, A. A., Ashraf, M., Graves, S. F., Ragasa, W., Humbird, T. L., Greaver, J. L., Cantu, C., Swain, J. L., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090960 · Cited by 55
Self-citationLi, M., Dai, Y., Zhu, Y., Fu, C.-L., Tan, V. Y., Wang, Y., Wang, X., Hong, X., Liu, Q., Li, T., et al. (2016) · Scientific Reports · doi:10.1038/srep27899 · Cited by 51
Self-citationMethicillin-resistant Staphylococcus aureus antibiotic resistance and virulence
Xia, J., Gao, J., Kokudo, N., Hasegawa, K., & Tang, W. (2013) · BioScience Trends · doi:10.5582/bst.2013.v7.3.113 · Cited by 57
Qiu, J., Niu, X., Wang, J., Xing, Y., Leng, B., Dong, J., Li, H., Luo, M., Zhang, Y., Dai, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033032 · Cited by 47
An antidote for Staphylococcus aureus pneumonia?
DeLeo, F. R., & Otto, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080167 · Cited by 46
Self-citationMonecke, S., Müller, E., Büchler, J., Stieber, B., & Ehricht, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100427 · Cited by 49
Sharma‐Kuinkel, B. K., Ahn, S. H., Rude, T. H., Zhang, Y., Tong, S. Y. C., Ruffin, F., Genter, F. C., Braughton, K. R., DeLeo, F. R., Barriere, S. L., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06219-11 · Cited by 47
Self-citationSpaulding, A. R., Satterwhite, E. A., Lin, Y., Chuang-Smith, O. N., Frank, K. L., Merriman, J. A., Schaefers, M. M., Yarwood, J. M., Peterson, M. L., & Schlievert, P. M. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00018 · Cited by 53
“Staphylococcal α-toxin is required for causation of skin infections (Kobayashi et al., 2011), and both α-toxin and SAgs, including a newly described SAg SEl-X, are required for fatal necrotizing pneumonia (CDC, 1999; Fey et al., 2003; Bubeck Wardenburg et al., 2007; Strandberg et al., 2010; Wilson et al., 2011).”
BackgroundFigueiredo, A. M. S., & Ferreira, F. A. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276140016 · Cited by 61
“A study using an animal model of pneumonia, i.e., mice infected with hla knock- outs derived from CA-MRSA isolates of the USA300 or USA400 clones, suggested the involvement of Hla in this type of infection (Wardenburg et al. 2007).”
BackgroundMethodGoldmann, O., Tuchscherr, L. P. N., Rohde, M., & Medina, E. (2015) · Cellular Microbiology · doi:10.1111/cmi.12550 · Cited by 45
Regulation ofStaphylococcus aureusVirulence
Jenul, C., & Horswill, A. R. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch41 · Cited by 45
Nygaard, T. K., DeLeo, F. R., & Voyich, J. M. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f64819 · Cited by 50
Self-citationEvolutionary blueprint for host- and niche-adaptation in Staphylococcus aureus clonal complex CC30
Mcgavin, M. J., Arsic, B., & Nickerson, N. N. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00048 · Cited by 54
“Most notable among the pseudogenes was a CAG to TAG transition at Gln113 of hla encoding α-hemolysin (Hla), which is a major lethal virulence factor of CA-MRSA (Bubeck Wardenburg et al., 2007).”
BackgroundNickerson, N. N., Ip, J., Passos, D. T., & Mcgavin, M. J. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06974.x · Cited by 49
“We next conducted a temporal analysis of proSspB secretion, relative to SspA, and a-hemolysin (Hla), which is an important secreted virulence factor of S. aureus (Bubeck Wardenburg et al. 2007; Wardenburg and Schneewind, 2008).”
BackgroundMethicillin-SusceptibleStaphylococcus aureusin Skin and Soft Tissue Infections, Northern Italy
Tinelli, M., Monaco, M., Vimercati, M., Ceraminiello, A., & Pantosti, A. (2009) · Emerging infectious diseases · doi:10.3201/eid1502.080010 · Cited by 45
Key Genetic Elements and Regulation Systems in Methicillin-Resistant Staphylococcus Aureus
Hao, H., Dai, M., Wang, Y., Huang, L., & Yuan, Z. (2012) · Future Microbiology · doi:10.2217/fmb.12.107 · Cited by 50
“, SCCmec) has drawn the attention of lots of researchers [20–23].”
BackgroundGuo, N., Zhao, X., Li, W., Shi, C., Meng, R., Liu, Z., & Yu, L. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000106 · Cited by 44
“Staphylococcus aureus (S. aureus) is one of the most signifi- cant pathogens in both hospitals and the community and can cause numerous syndromes in humans, such as endo- carditis, pneumonia and septicaemia (Bubeck Wardenburg et al., 2007; Panizzi et al., 2011).”
BackgroundWelsh, K. J., Abbott, A. N., Lewis, E. M., Gardiner, J. M., Kruzel, M. C., Lewis, C. T., Mohr, J., Wanger, A. R., & Armitige, L. Y. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01949-09 · Cited by 44
Graves, S. F., Kobayashi, S. D., Braughton, K. R., Diep, B. A., Chambers, H. F., Otto, M., & DeLeo, F. R. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.02.005 · Cited by 42
Self-citationDiep, B. A., Hilliard, J. J., Le, V. T. M., Tkaczyk, C., Le, H. N., Tran, V. G., Rao, R. L., Dip, E. C., Franchi, E. P. L. P., Cha, P., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02456-16 · Cited by 43
Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia
Vlaeminck, J., Raafat, D., Surmann, K., Timbermont, L., Normann, N., Sellman, B. R., van Wamel, W. J. B., & Malhotra‐Kumar, S. (2020) · Toxins · doi:10.3390/toxins12110721 · Cited by 44
“The importance of Hla as a virulence factor in SAP has been researched in mouse, rabbit and ferret pneumonia models [72,85,86,115], with studies reporting a disruptive effect on the air-blood barrier [116].”
BackgroundInfluentialKnop, J., Hanses, F., Leist, T., Archin, N. M., Buchholz, S., Gläsner, J., Gessner, A., & Wege, A. K. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv073 · Cited by 43
Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence
Yoong, P., & Torres, V. J. (2015) · Nature Communications · doi:10.1038/ncomms9125 · Cited by 41
Genetic nature and virulence of community-associated methicillin-resistant Staphylococcus aureus
Yamamoto, T., Hung, W., Takano, T., & Nishiyama, A. (2013) · Biomedicine · doi:10.1016/j.biomed.2012.12.001 · Cited by 49
Statt, S. N., Ruan, J., Hung, L., Chang, C.-Y., Huang, C.-T., Lim, J. H., Li, J., Wu, R., & Kao, C. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0391oc · Cited by 45
Guerra, F. E., Addison, C. B., de Jong, N. W. M., Azzolino, J., Pallister, K. B., van Strijp, J. A. G., & Voyich, J. M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4vmab0316-100rr · Cited by 50
Staphylococcus aureus α-Hemolysin Promotes Platelet-Neutrophil Aggregate Formation
Parimon, T., Li, Z., Bolz, D. D., McIndoo, E. R., Bayer, C. R., Stevens, D. L., & Bryant, A. E. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit235 · Cited by 45
Hota, B. N., Lyles, R. D., Rim, J., Popovich, K. J., Rice, T., Aroutcheva, A. A., & Weinstein, R. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir472 · Cited by 43
Yamaguchi, T., Okamura, S., Miura, Y., Koyama, S., Yanagisawa, H., & Matsumoto, T. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0153 · Cited by 42
Crémieux, A., Saleh‐Mghir, A., Danel, C. J., Couzon, F., Dumitrescu, O., Lilin, T., Perronne, C., Étienne, J., Lina, G., & Vandenesch, F. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit840 · Cited by 44
Schlievert, P. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/605333 · Cited by 46
Ezekwe, E., Weng, C., & Duncan, J. A. (2016) · Toxins · doi:10.3390/toxins8040095 · Cited by 41
Jiang, L., Li, H., Wang, L., Song, Z., Shi, L., Li, W., Deng, X., & Wang, J. (2016) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1507.07091 · Cited by 41
Teymournejad, O., Li, Z., Beesetty, P., Yang, C. W., & Montgomery, C. P. (2023) · npj Vaccines · doi:10.1038/s41541-022-00598-3 · Cited by 41
Croze, M., Dauwalder, O., Dumitrescu, O., Badiou, C., Gillet, Y., Genestier, A., Vandenesch, F., Étienne, J., & Lina, G. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02650.x · Cited by 40
Staphylococcus aureus Pore-Forming Toxins
Robles, T. R., & Torres, V. J. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_16 · Cited by 41
Host Response Signature to Staphylococcus aureus Alpha-Hemolysin Implicates Pulmonary Th17 Response
Frank, K. M., Zhou, T., Moreno-Vinasco, L., Hollett, B., Garcia, J. G. N., & Bubeck Wardenburg, J. (2012) · Infection and Immunity · doi:10.1128/iai.00191-12 · Cited by 38
Morgene, M. F., Botelho-Nevers, É., Grattard, F., Pillet, S., Berthelot, P., Pozzetto, B., & Verhoeven, P. O. (2018) · Virulence · doi:10.1080/21505594.2018.1504561 · Cited by 40
Ji, Y., Cheng, M., Zhai, S., Xi, H., Cai, R., Wang, Z., Zhang, H., Wang, X., Xue, Y., Li, X., et al. (2018) · Veterinary Microbiology · doi:10.1016/j.vetmic.2018.12.021 · Cited by 39
Community-associated Staphylococcus aureus infections in children
Rojo, P., Barrios, M., Palacios, A., Gómez, C., & Cháves, F. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.34 · Cited by 52
Kim, G.-L., Hooven, T. A., Norambuena, J., Li, B., Boyd, J. M., Yang, J. H., & Parker, D. (2021) · mBio · doi:10.1128/mbio.00814-21 · Cited by 38
Weidenmaier, C., McLoughlin, R. M., & Lee, J. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013227 · Cited by 45
Lowy, F. D. (2007) · Nature Medicine · doi:10.1038/nm1207-1418 · Cited by 42
Staphylococcus aureus: setting its sights on the human innate immune system
Buchan, K. D., Foster, S. J., & Renshaw, S. A. (2019) · Microbiology · doi:10.1099/mic.0.000759 · Cited by 43
“aureus, and is present in the core genome of almost all sequenced strains [82].”
BackgroundInfluentialKloft, N., Neukirch, C., von Hoven, G., Bobkiewicz, W., Weis, S., Böller, K., & Husmann, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.379883 · Cited by 40
“The small -barrel pore forming -toxin is an important virulence factor of Staphylococcus aureus, (36, 37).”
BackgroundMolecular Basis of Pathogenicity
Smeltzer, M. S., Lee, C. Y., Harik, N., & Hart, M. E. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch4 · Cited by 43
Hartmann, T., Baronian, G., Nippe, N., Voss, M., Schulthess, B., Wolz, C., Eisenbeis, J., Schmidt‐Hohagen, K., Gaupp, R., Sunderkötter, C. H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.584979 · Cited by 36
“aureus (51, 52); specifically, the level of α-toxin correlated with disease severity in this animal model (53).”
Control of Foodborne Staphylococcus aureus by Shikonin, a Natural Extract
Wan, Y., Wang, X., Zhang, P., Zhang, P., Kou, M., Shi, C., Peng, X., & Wang, X. (2021) · Foods · doi:10.3390/foods10122954 · Cited by 36
Save, J., Que, Y., Entenza, J. M., Kolenda, C., Laurent, F. J., & Resch, G. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023080 · Cited by 36
Chen, Y., Yeh, A. J., Cheung, G. Y. C., Villaruz, A. E., Tan, V. Y., Joo, H., Chatterjee, S. S., Yu, Y., & Otto, M. J. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu462 · Cited by 36
Self-citationSzabados, F., Becker, K., von Eiff, C., Kaase, M., & Gatermann, S. G. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.05.005 · Cited by 34
Osawa, R., Williams, K. L., & Singh, N. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.10.002 · Cited by 35
Castleman, M. J., Febbraio, M., & Hall, P. R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500500 · Cited by 39
Lee, S. S., Kim, Y.-J., Chung, D. R., Jung, K., & Kim, J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00297-09 · Cited by 36
Zhou, W., Jin, Y., Liu, X., Chen, Y., Shen, P., & Xiao, Y. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02037-21 · Cited by 32
Polydiacetylene-Nanoparticle-Functionalized Microgels for Topical Bacterial Infection Treatment
Tao, J., Xu, X., Wang, S., Kang, T., Guo, C., Liu, X., Cheng, H., Liu, Y., Jiang, X. L., Mao, J., et al. (2019) · ACS Macro Letters · doi:10.1021/acsmacrolett.9b00196 · Cited by 34
Zhang, J., Yang, F., Zhang, X., Jing, H., Ren, C., Cai, C., Dong, Y., Zhang, Y., Zou, Q., & Zeng, H. (2015) · Scientific Reports · doi:10.1038/srep15553 · Cited by 31
Stulik, L., Rouha, H., Labrousse, D., Visram, Z., Badarau, A., Maierhofer, B., Groß, K., Weber, S., Kramarić, M. D., Glojnarić, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41826-6 · Cited by 31
Antimicrobial lipids in nano-carriers for antibacterial delivery
Zhang, Q., Wu, W., Zhang, J., & Xia, X. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1681434 · Cited by 31
GPER activation protects against epithelial barrier disruption by Staphylococcus aureus α-toxin
Triplett, K. D., Pokhrel, S., Castleman, M. J., Daly, S. M., Elmore, B. O., Joyner, J. A., Sharma, G., Herbert, G., Campen, M. J., Hathaway, H. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37951-3 · Cited by 35
Numata, S., Nagata, M., Mao, H., Sekimizu, K., & Kaito, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554329 · Cited by 30
Neutrophil evasion strategies by Streptococcus pneumoniae and Staphylococcus aureus
Lewis, M. L., & Surewaard, B. G. J. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2737-2 · Cited by 31
Bao, Y., Li, Y., Jiang, Q., Zhao, L., Xue, T., Hu, B., & Sun, B. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.03.004 · Cited by 31
Antibiotic options for treating community-acquired MRSA
Powell, J. P., & Wenzel, R. P. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.3.299 · Cited by 33
Zhao, H., Wu, X., Wang, B., Shen, L., Rao, L., Wang, X., Zhang, J., Xiao, Y., Xu, Y., Yu, J., et al. (2023) · mSystems · doi:10.1128/msystems.01242-22 · Cited by 28
Key Role of α-Toxin in Fatal Pneumonia Caused by Staphylococcus aureus Sequence Type 398
Bonesso, M. F., Yeh, A. J., Villaruz, A. E., Joo, H., McCausland, J. W., Fortaleza, C. M. C. B., Cavalcante, R. D. S., Sobrinho, M. T., Ronchi, C. F., Cheung, G. Y. C., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1225le · Cited by 28
Self-citationEpidemiology and Virulence of Community-Associated MRSA
Kennedy, A. D., & DeLeo, F. R. (2009) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2009.09.004 · Cited by 34
Self-citationGarófalo, A. N., Giai, C., Lattar, S. M., Gardella, N., Mollerach, M. E., Kahl, B. C., Becker, K., Prince, A. S., Sordelli, D. O., & Gómez, M. I. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis311 · Cited by 29
Deplanche, M., Alekseeva, L. G., Semenovskaya, K., Fu, C.-L., Dessauge, F., Finot, L., Petzl, W., Zerbe, H., Loir, Y. L., Rainard, P., et al. (2016) · Infection and Immunity · doi:10.1128/iai.01330-15 · Cited by 27
Self-citationPark, C., Lee, D., Choi, S., Park, S. H., Choi, J., Yoo, J.-H., Hur, J., & Shin, W. (2008) · Infection and Chemotherapy · doi:10.3947/ic.2008.40.2.121 · Cited by 28
Dumitrescu, O., Tristan, A., Meugnier, H., Bes, M., Gouy, M., Étienne, J., Lina, G., & Vandenesch, F. (2008) · The Journal of Infectious Diseases · doi:10.1086/590914 · Cited by 27
Xiao, Y., Han, W., Wang, B., Xu, Y., Zhao, H., Wang, X., Rao, L., Zhang, J., Shen, L., Zhou, H., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2165969 · Cited by 26
Targeting the host–pathogen interface for treatment of Staphylococcus aureus infection
Park, B., & Liu, G. Y. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0297-1 · Cited by 29
Baldan, R., Rancoita, P. M. V., Serio, C. D., Mazzotti, M. F., Cichero, P., Ossi, C. M., Biancardi, A., Nizzero, P., Saracco, A., Scarpellini, P., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku467 · Cited by 26
Pichereau, S., Pantrangi, M., Couet, W. R., Badiou, C., Lina, G., Shukla, S. K., & Rose, W. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05113-11 · Cited by 26
Omae, Y., Hanada, Y., Sekimizu, K., & Kaito, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.495051 · Cited by 26
“aureus hemolysin gene deletion mutants exhibit attenuated virulence against mammals (2, 3), indicating that S.”
BackgroundAntibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases
Speziale, P., Rindi, S., & Pietrocola, G. (2018) · Microorganisms · doi:10.3390/microorganisms6010025 · Cited by 26
Nickol, M. E., Ciric, J., Falcinelli, S. D., Chertow, D. S., & Kindrachuk, J. (2019) · Viruses · doi:10.3390/v11020116 · Cited by 27
“This may suggest a critical role for hla in the immediate stages of secondary MRSA infection pathogenesis and may contribute to co-infection pathogenesis, as α-hemolysin is related to clinical pneumonia [24,50].”
BackgroundCameron, D. R., Lin, Y.-H., Trouillet‐Assant, S., Dyon-Tafani, V., Kostoulias, X., Mouhtouris, E., Skinner, N. A., Visvanathan, K., Baines, S. L., Howden, B. P., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.03.027 · Cited by 25
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies
Hsieh, R. C., Liu, R., Burgin, D. J., & Otto, M. J. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2242585 · Cited by 26
Self-citationMethicillin-resistantStaphylococcus aureuspneumonia in adults
Woods, C. J., & Colice, G. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.940323 · Cited by 29
Ito, T., Iijima, M., Fukushima, T., Nonoyama, M., Ishii, M., Baranovich, T., Otsuka, T., Takano, T., & Yamamoto, T. (2008) · Emerging infectious diseases · doi:10.3201/eid1408.070391 · Cited by 26
Wu, K., Conly, J. M., Surette, M. G., Sibley, C. D., Elsayed, S., & Zhang, K. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-274 · Cited by 27
Wu, Y., Liu, X., Akhgar, A., Li, J. J., Mok, H., Sellman, B. R., Yu, L., Roskos, L. K., Esser, M. T., & Ruzin, A. V. (2017) · Infection and Immunity · doi:10.1128/iai.00671-17 · Cited by 25
Stoll, H., Ost, M., Singh, A., Mehling, R., Neri, D., Schäfer, I., Velić, A., Maček, B., Kretschmer, D., Weidenmaier, C., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00321 · Cited by 27
Davido, B., Saleh‐Mghir, A., Laurent, F. J., Danel, C. J., Couzon, F., Gatin, L., Vandenesch, F., Rasigade, J., & Crémieux, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157133 · Cited by 24
Foster, C. E., Yarotsky, E., Mason, E. O., Kaplan, S. L., & Hultén, K. G. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix036 · Cited by 24
Bloes, D. A., Haasbach, E., Hartmayer, C., Hertlein, T., Klingel, K., Kretschmer, D., Planz, O., & Peschel, A. (2017) · Infection and Immunity · doi:10.1128/iai.00620-17 · Cited by 29
Staphylococcus aureus Secreted Toxins and Extracellular Enzymes
Tam, K., & Torres, V. J. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch40 · Cited by 39
Zhang, P., Miao, X., Zhou, L., Cui, B., Zhang, J., Xu, X., Wu, C., Peng, X., & Wang, X. (2020) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2019.2774 · Cited by 23
“Hla and PVL genes are a typical feature of CA-MRSA (Mcclure et al. , 2006).”
Yang, F., Suo, M., Weli, H. K., Wong, M., Junidi, A., Cummings, C., Johnson, R., Mallory, K., Liu, A. Y., Greenberg, Z. J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113394 · Cited by 23
Boakes, E., Kearns, A., Badiou, C., Lina, G., Hill, R. L., & Ellington, M. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06421-11 · Cited by 23
Metadata
- Authors
- Bubeck Wardenburg, J., Bae, T., Otto, M., DeLeo, F. R., & Schneewind, O.
- Affiliations
- Indiana University Northwest (US)
- National Institutes of Health (US)
- University of Chicago (US)
- Venue
- Nature Medicine
- Published
- 2007-12
- Volume
- 13
- Issue
- 12
- Pages
- 1405-1406
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2044206614
- Cited by
- 492
- References
- 8
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 17 · 2023: 20 · 2022: 11 · 2021: 15 · 2020: 14 · 2019: 23 · 2018: 27 · 2017: 18 · 2016: 24 · 2015: 32 · 2014: 41 · 2013: 48 · 2012: 42
- FWCI
- 23.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- Staphylococcus aureus pneumonia, alpha-hemolysin, Panton-Valentine leukocidin, cytotoxin, epithelial lining fluid, lung epithelial barrier, pneumococcal pneumonia, monoclonal antibodies, G protein-coupled estrogen receptor, sensory deprivation
- MeSH terms
- Alleles, Animals, Bacterial Toxins, Exotoxins, Hemolysin Proteins, Humans, Leukocidins, Mice, Inbred C57BL, Models, Biological, Pneumonia, Staphylococcal, Staphylococcus aureus, Virulence, Drug Resistance, Bacterial, Escherichia coli Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.